Apr 24, 2025 / 09:00AM GMT
Presentation
Apr 24, 2025 / 09:00AM GMT
=====================
Corporate Participants
=====================
* Kae Miyata
Chugai Pharmaceutical Co Ltd - Head of Corporate Communications Department
* Osamu Okuda
Chugai Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Kusano Tsukasa
Chugai Pharmaceutical Co Ltd - Executive Vice President Supervisory responsibility for Project & Lifecycle Management
* Iwaaki Taniguchi
Chugai Pharmaceutical Co Ltd - Director, Executive Vice President, and Chief Financial Officer
* Takano Junichi
Chugai Pharmaceutical Co Ltd - Head of Marketing & Sales Division
=====================
Conference Call Participants
=====================
* Matsubara-san
Nomura Securitie - Analyst
* Seiji Wakao
JPMorgan Securities - Analyst
* Shinichiro Muraoka
Morgan Stanley MUFG Securities - Analyst
* Hidemaru Yamaguchi
Citigroup Inc - Analyst
* Tony Ren
Macquarie Capital -
Chugai Pharmaceutical Co Ltd
(MEX:4519N)
MXN
825.61
(0%)
Market Cap: 1.31 Tn
Enterprise Value: 1.21 Tn
PE Ratio: 26.66
PB Ratio: 6.32
GF Score: 97/100 Q1 2025 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript
Apr 24, 2025 / 09:00AM GMT
Release Date Price:
MXN1121.87
(+22.29%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot